|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0021083,
umls-concept:C0026764,
umls-concept:C0030705,
umls-concept:C0205197,
umls-concept:C0205314,
umls-concept:C0450442,
umls-concept:C0544452,
umls-concept:C0574032,
umls-concept:C0679622,
umls-concept:C0728938,
umls-concept:C1521991
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2009-6-22
|
|
pubmed:abstractText |
To investigate post-transplant immunotherapy with escalating donor-lymphocyte infusions (DLI) and novel agents (thalidomide, bortezomib, and lenalidomide) to target complete remission (CR).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1873-2399
|
|
pubmed:author |
pubmed-author:AtanackovicDjordjeD,
pubmed-author:AyukFrancisF,
pubmed-author:BacherUlrikeU,
pubmed-author:BadbaranAnitaA,
pubmed-author:CorradiniPaoloP,
pubmed-author:FehseBorisB,
pubmed-author:HildebrandYorkY,
pubmed-author:KlyuchnikovEvgenyE,
pubmed-author:KrögerNicolausN,
pubmed-author:LioznovMichaelM,
pubmed-author:NaglerArnonA,
pubmed-author:SchillingGeorgiaG,
pubmed-author:SchwarzSabineS,
pubmed-author:ShimoniAvichaiA,
pubmed-author:ZabelinaTatjanaT,
pubmed-author:ZanderAxelA,
pubmed-author:ZeschkeSilkeS
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
37
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
791-8
|
|
pubmed:meshHeading |
pubmed-meshheading:19487069-Adult,
pubmed-meshheading:19487069-Aged,
pubmed-meshheading:19487069-Antineoplastic Agents,
pubmed-meshheading:19487069-Cell Transplantation,
pubmed-meshheading:19487069-Female,
pubmed-meshheading:19487069-Flow Cytometry,
pubmed-meshheading:19487069-Humans,
pubmed-meshheading:19487069-Immunotherapy,
pubmed-meshheading:19487069-Lymphocytes,
pubmed-meshheading:19487069-Male,
pubmed-meshheading:19487069-Middle Aged,
pubmed-meshheading:19487069-Multiple Myeloma,
pubmed-meshheading:19487069-Remission Induction,
pubmed-meshheading:19487069-Stem Cell Transplantation,
pubmed-meshheading:19487069-Survival Analysis,
pubmed-meshheading:19487069-Transplantation, Homologous
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Post-transplant immunotherapy with donor-lymphocyte infusion and novel agents to upgrade partial into complete and molecular remission in allografted patients with multiple myeloma.
|
|
pubmed:affiliation |
Department for Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. nkroeger@uke.uni-hamburg.de
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
